The purchase terms are based on the hospital’s valuation of $73 million and a percent of the hospital’s available cash, from which MedCath expects to net $60 million. The net amount anticipated to be received by MedCath includes repayment of inter-company debt owed by Arkansas Heart Hospital, according to the release.
The sale is subject to MedCath stockholder approval and other conditions.
Read the MedCath release on its sale of Arkansas Heart Hospital.
Related Articles on MedCath:
MedCath Sells Coastal Carolina Heart to New Hanover Regional Medical Center
Duke, LifePoint Joint Venture Acquires Cath Labs From MedCath
MedCath Completes Sale of Texsan Heart Hospital to San Antonio Health System
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
